Skip to main navigation Skip to search Skip to main content

Bevacizumab therapy normalizes the pathological intraocular environment beyond neutralizing VEGF

Research output: Contribution to journal › Article › peer-review

Original languageEnglish
Pages (from-to)2175-2184
Number of pages10
JournalMolecular Vision
Volume16
StatePublished - Oct 27 2010
Externally publishedYes

ASJC Scopus Subject Areas

  • Ophthalmology

Keywords

  • Aqueous Humor/drug effects
  • Eye/drug effects
  • Antibodies, Monoclonal, Humanized
  • Intravitreal Injections
  • Humans
  • Vascular Endothelial Growth Factor A/immunology
  • Female
  • Male
  • Antibodies, Neutralizing/immunology
  • Antibodies, Monoclonal/administration & dosage
  • Bevacizumab
  • Cluster Analysis

Cite this